Squarepoint
TNDM icon

Squarepoint’s Tandem Diabetes Care TNDM Stock Holding History

Squarepoint’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-180,660
Closed -$3.37M – 5004
2025
Q2 		$3.37M Buy
180,660
+56,777
+46% +$1.12M ﹤0.01% 1725
2025
Q1 		$2.37M Buy
123,883
+60,564
+96% +$1.77M ﹤0.01% 1952
2024
Q4 		$2.28M Buy
63,319
+27,389
+76% +$926K ﹤0.01% 2304
2024
Q3 		$1.52M Sell
35,930
-85,240
-70% -$3.61M ﹤0.01% 2273
2024
Q2 		$4.88M Sell
121,170
-292,789
-71% -$12.2M 0.01% 1402
2024
Q1 		$14.7M Sell
413,959
-42,561
-9% -$1.14M 0.03% 771
2023
Q4 		$13.5M Buy
456,520
+303,313
+198% +$6.29M 0.03% 771
2023
Q3 		$3.18M Sell
153,207
-16,673
-10% -$458K 0.01% 1479
2023
Q2 		$4.17M Buy
+169,880
New +$5.47M 0.01% 1178
2023
Q1 		– Sell
-68,321
Closed -$2.83M – 3820
2022
Q4 		$3.07M Sell
68,321
-299,369
-81% -$13.6M 0.01% 1114
2022
Q3 		$17.6M Buy
367,690
+9,564
+3% +$524K 0.09% 258
2022
Q2 		$21.2M Buy
358,126
+254,958
+247% +$20.9M 0.12% 188
2022
Q1 		$12M Sell
103,168
-8,195
-7% -$957K 0.05% 391
2021
Q4 		$16.8M Buy
111,363
+28,957
+35% +$3.91M 0.04% 359
2021
Q3 		$9.84M Buy
82,406
+62,315
+310% +$6.87M 0.03% 504
2021
Q2 		$1.96M Sell
20,091
-65,930
-77% -$5.88M 0.01% 1199
2021
Q1 		$7.59M Buy
+86,021
New +$7.99M 0.04% 460
2020
Q4 		– Sell
-16,256
Closed -$1.84M – 3259
2020
Q3 		$1.84M Buy
16,256
+1,364
+9% +$143K 0.02% 675
2020
Q2 		$1.47M Sell
14,892
-32,890
-69% -$2.62M 0.02% 756
2020
Q1 		$3.08M Sell
47,782
-2,470
-5% -$173K 0.08% 320
2019
Q4 		$3M Buy
+50,252
New +$3.1M 0.02% 692
2019
Q3 		– Sell
-66,740
Closed -$4.31M – 2672
2019
Q2 		$4.31M Buy
66,740
+21,094
+46% +$1.36M 0.04% 480
2019
Q1 		$2.9M Buy
45,646
+34,224
+300% +$1.8M 0.03% 622
2018
Q4 		$434K Sell
11,422
-43,246
-79% -$1.53M 0.01% 1329
2018
Q3 		$2.34M Buy
+54,668
New +$1.91M 0.03% 665
2018
Q2 		– Sell
-39,898
Closed -$198K – 2048
2018
Q1 		$198K Buy
+39,898
New +$129K ﹤0.01% 1499
2017
Q3 		– Sell
-1,165
Closed -$9K – 1880
2017
Q2 		$9K Buy
+1,165
New +$10.8K ﹤0.01% 1493

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint's TNDM Position: Q3 2025 in Review

Squarepoint sold out of Tandem Diabetes Care (TNDM) in Q3 2025, closing a stake of 180,660 shares — an estimated $3.37M sold.

Squarepoint first reported a position in TNDM in Q2 2017 and held it in 27 quarters. The position peaked at $21.2M in Q2 2022. 255 funds tracked by Wall St. Rank hold TNDM as of Q3 2025.

  • Squarepoint reported no remaining Tandem Diabetes Care position as of Q3 2025 after selling out during the quarter.
  • Squarepoint sold 180,660 Tandem Diabetes Care shares in Q3 2025, an estimated $3.37M.
  • Squarepoint first reported a position in Tandem Diabetes Care in Q2 2017 and held it in 27 quarters.
  • Squarepoint's Tandem Diabetes Care position peaked at $21.2M in Q2 2022.
  • 255 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2025.

Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.